Labour calls for detail on how the government will increase coronavirus testing ten-fold by the end of April.
Category Archives: Longevity
Health24.com | Certain health conditions increase risks for severe coronavirus cases
New research suggests that having an underlying health condition might be one of the most significant risk factors for developing a severe case of the new coronavirus.
Scientists at the US Centers for Disease Control and Prevention took a look at a group of US adult Covid-19 patients and found roughly three-quarters of those who wound up in the hospital had at least one underlying health issue.
For 457 patients who were admitted to intensive care, 78% had other health conditions, while 71% of 732 patients admitted to the hospital, but not intensive care, had at least one other health issue.
The mortality data showed an even stronger correlation: Among all hospitalised Covid-19 adult patients with complete information on underlying conditions or risk factors, 184 deaths occurred. Of those, 173 (94%) involved patients with at least one underlying condition, according to the CDC’s Covid-19 Response Team, led by researcher Nancy Chow.
New findings ‘all too familiar’
Those conditions include diseases that strike people of all ages, including asthma and diabetes, along with heart disease and lung disease.
Unfortunately, those very conditions are quite common among Americans, the researchers noted: In 2018, the prevalence of diagnosed diabetes among US adults was just over 10%, while the prevalence of heart disease was 10.6% in 2017. Meanwhile, the prevalence of COPD (chronic obstructive pulmonary disease) among US adults was almost 6% and the prevalence of asthma among persons of all ages was nearly 8% in 2018.
The findings were recently published in the CDC publication Morbidity and Mortality Weekly Report.
Dr Robert Glatter is an emergency physician in New York City, tasked with treating many patients hit by coronavirus. He said the new findings are all too familiar.
“On the front lines what we are seeing is that patients with chronic lung disease, cardiovascular disease and diabetes are at higher risk for admission, as well as respiratory failure due to ARDS,” he said. “Patients with asthma, COPD, as well as sleep apnoea are at elevated risk for adverse outcomes including pneumonia, ARDs, and subsequent intubation.
That doesn’t mean that everyone with these conditions is certain to suffer severe illness, Glatter stressed.
Underlying conditions ‘a big player’
“It’s unclear if those patients with underlying chronic disease who adequately manage their conditions are at lower risk for complications and adverse outcomes,” he said.
Underlying conditions can be a big player in Covid-19 severity, but many young adults mistakenly believe that only older people are affected by the coronavirus – a misconception that puts themselves and others at risk, experts warned.
A growing number of 20- to 44-year-old Americans have been hospitalised for Covid-19.
While the rate of Covid-19 deaths is highest for those older than 85, the rate of confirmed cases is highest (29%) among 20- to 44-year-olds, according to the CDC.
Those between 65 and 84 years of age represented more than a third of hospitalised patients, the CDC says, but 20% of hospitalised patients were between 20 and 44.
It’s highly likely that someone in that younger group knows someone from a high-risk group, said Dr Michael Chang, an assistant professor of paediatrics at the University of Texas Health Science Center at Houston.
“Even if your individual risk of severe disease is low, it would be very unfair for those high-risk patients if your actions exposed them to what could be life-threatening disease,” Chang said in a UT Health news release.
Take physical distancing seriously
Young adults need to be aware that while their risk of death if they contract Covid-19 is lower than for older adults, they can spread the illness to their more vulnerable parents, grandparents and other loved ones, said Dr George Delclos, a professor of public health at UT Health.
High-risk people need to take physical distancing seriously to avoid contracting the coronavirus, said Catherine Troisi, an infectious disease epidemiologist at UT Health School of Public Health.
People with elevated risk include those who have underlying health conditions such as chronic lung disease, diabetes or heart disease; are overweight; have a weakened immune system; are pregnant; or are older than 65.
But everyone is at risk, including young people, Troisi emphasised.
READ | Doctors warned against prescribing unproven medication for Covid-19
READ | Odds of hospitalisation, death with coronavirus rise steadily with age
READ | Coronavirus infection likely worse for vapers and smokers
Image credit: CDC, Unsplash
Coronavirus: How NHS Nightingale was built in just nine days
How London’s ExCel centre was transformed into a hospital to treat coronavirus patients.
Health24.com | Mild coronavirus cases often appear with only gastro symptoms
When most people think of the new coronavirus, they imagine symptoms such as a dry cough and high fever. But new research out of China shows that a minority of cases appear with gastrointestinal symptoms only.
In about one-quarter of patients in the new study, diarrhoea and other digestive symptoms were the only symptoms seen in mild Covid-19 cases, and those patients sought medical care later than those with respiratory symptoms.
“Failure to recognise these patients early and often may lead to unwitting spread of the disease among outpatients with mild illness, who remain undiagnosed and unaware of their potential to infect others,” said a team from Union Hospital and Tongji Medical College in Wuhan, China, the original epicentre of the coronavirus pandemic.
“The data in this study highlight the presence and features of this important subgroup of Covid-19 patients and should be confirmed in larger international studies,” the researchers concluded.
Virus throws a curveball
One US expert agreed.
“We are only now learning the varied spectrum of symptoms for patients who present with Covid-19,” said Dr Robert Glatter, an emergency medicine physician at Lenox Hill Hospital in New York City.
“This virus has thrown a curveball at us, as we now realise that gastrointestinal symptoms may be the initial signs of the disease, even without cough, fever, or difficulty breathing,” he said. “The good news is that the majority of patients with gastrointestinal symptoms typically have mild disease.”
In the new study, the research team tracked data from 206 patients with mild Covid-19. Nearly one-quarter (48) had digestive symptoms only, 69 displayed both digestive and respiratory symptoms, and 89 had respiratory symptoms only.
Of the patients with digestive symptoms, 67 had diarrhoea, the study found. Of those, about one in five had diarrhoea as the first symptom in the course of their illness.
Patients with digestive symptoms ill for longer
Diarrhoea lasted between one to 14 days, with an average duration of more than five days and a frequency of about four bowel movements a day.
About one-third of patients with a digestive symptom did not have a fever, the investigators found.
Patients with digestive symptoms took longer to seek medical care than those with respiratory symptoms (16 days versus 11 days), a finding that was consistent with previous research.
The new study also found that patients with digestive symptoms had a longer total time between the start of symptoms and being clear of the coronavirus, were more likely to have coronavirus in their faeces (73% versus 14%), and were ill longer than those with respiratory symptoms.
The study was recently published online in the American Journal of Gastroenterology.
Study considered ‘vital’
The Chinese team stressed that of course there are many illnesses circulating in the community that can trigger gastrointestinal symptoms, “and most instances of new-onset diarrhoea, nausea, vomiting, or low appetite are not from Covid-19.”
Still, “clinicians should recognise that new-onset, acute digestive symptoms in a patient with a possible Covid-19 contact should at least prompt consideration of the illness,” the researchers explained.
Dr Brennan Spiegel is co-editor-in-chief of the journal. He called the study “vital because it represents the 80% or more of patients who do not have severe or critical disease. This is about the more common scenario of people in the community struggling to figure out if they might have Covid-19 because of new-onset diarrhoea, nausea, or vomiting.”
Glatter agreed.
“It’s vital to recognise this key aspect of how the disease presents, since it can trigger the need for self-quarantine,” he said.
READ | Almost half of coronavirus patients have digestive symptoms
READ | Coronavirus: Why the 14-day quarantine period?
READ | Coronavirus: Basic protective measures
Image credit: Kolar IO, Unsplash
Trial drug can significantly block early stages of COVID-19 in engineered human tissues
An international team led by University of British Columbia researcher Dr. Josef Penninger has found a trial drug that effectively blocks the cellular door SARS-CoV-2 uses to infect its hosts.
The findings, published today in Cell, hold promise as a treatment capable of stopping early infection of the novel coronavirus that, as of April 2, has affected more than 981,000 people and claimed the lives of 50,000 people worldwide.
The study provides new insights into key aspects of SARS-CoV-2, the virus that causes COVID-19, and its interactions on a cellular level, as well as how the virus can infect blood vessels and kidneys.
“We are hopeful our results have implications for the development of a novel drug for the treatment of this unprecedented pandemic,” says Penninger, professor in UBC’s faculty of medicine, director of the Life Sciences Institute and the Canada 150 Research Chair in Functional Genetics at UBC.
“This work stems from an amazing collaboration among academic researchers and companies, including Dr. Ryan Conder’s gastrointestinal group at STEMCELL Technologies in Vancouver, Nuria Montserrat in Spain, Drs. Haibo Zhang and Art Slutsky from Toronto and especially Ali Mirazimi’s infectious biology team in Sweden, who have been working tirelessly day and night for weeks to better understand the pathology of this disease and to provide breakthrough therapeutic options.”
ACE2 — a protein on the surface of the cell membrane — is now at centre-stage in this outbreak as the key receptor for the spike glycoprotein of SARS-CoV-2. In earlier work, Penninger and colleagues at the University of Toronto and the Institute of Molecular Biology in Vienna first identified ACE2, and found that in living organisms, ACE2 is the key receptor for SARS, the viral respiratory illness recognized as a global threat in 2003. His laboratory also went on to link the protein to both cardiovascular disease and lung failure.
While the COVID-19 outbreak continues to spread around the globe, the absence of a clinically proven antiviral therapy or a treatment specifically targeting the critical SARS-CoV-2 receptor ACE2 on a molecular level has meant an empty arsenal for health care providers struggling to treat severe cases of COVID-19.
“Our new study provides very much needed direct evidence that a drug — called APN01 (human recombinant soluble angiotensin-converting enzyme 2 — hrsACE2) — soon to be tested in clinical trials by the European biotech company Apeiron Biologics, is useful as an antiviral therapy for COVID-19,” says Dr. Art Slutsky, a scientist at the Keenan Research Centre for Biomedical Science of St. Michael’s Hospital and professor at the University of Toronto who is a collaborator on the study.
In cell cultures analyzed in the current study, hrsACE2 inhibited the coronavirus load by a factor of 1,000-5,000. In engineered replicas of human blood vessel and kidneys — organoids grown from human stem cells — the researchers demonstrated that the virus can directly infect and duplicate itself in these tissues. This provides important information on the development of the disease and the fact that severe cases of COVID-19 present with multi-organ failure and evidence of cardiovascular damage. Clinical grade hrsACE2 also reduced the SARS-CoV-2 infection in these engineered human tissues.
“Using organoids allows us to test in a very agile way treatments that are already being used for other diseases, or that are close to being validated. In these moments in which time is short, human organoids save the time that we would spend to test a new drug in the human setting,” says Núria Montserrat, ICREA professor at the Institute for Bioengineering of Catalonia in Spain.
“The virus causing COVID-19 is a close sibling to the first SARS virus,” adds Penninger. “Our previous work has helped to rapidly identify ACE2 as the entry gate for SARS-CoV-2, which explains a lot about the disease. Now we know that a soluble form of ACE2 that catches the virus away, could be indeed a very rational therapy that specifically targets the gate the virus must take to infect us. There is hope for this horrible pandemic.”
This research was supported in part by the Canadian federal government through emergency funding focused on accelerating the development, testing, and implementation of measures to deal with the COVID-19 outbreak.
A new way to fine-tune exotic materials: Thin, stretch and clamp
One way to change the properties of a material is to stretch it just a wee bit, so its atoms are farther apart but the bonds between them don’t break. This extra distance affects the behavior of electrons, which determine whether the material is an insulator or a conductor of electricity, for instance.
But for an important class of complex oxide materials, stretching doesn’t work so well; they’re as brittle as ceramic coffee cups and would break.
Scientists at the Department of Energy’s SLAC National Accelerator Laboratory and Stanford University have now found a way around this problem for a complex oxide known as LCMO. They created a super-thin, flexible membrane from the normally brittle material, used micromanipulators to stretch it on a tiny apparatus and glued it in place to preserve the stretch.
By applying gentle heat to melt the glue, they could release and stretch the same transparent membrane again and again and watch it flip from being an insulator to a conductor and back again. Stretching also changed its magnetic properties.
“We can really stretch and strain these things dramatically, by up to 8%,” said Harold Hwang, a professor at SLAC and Stanford and an investigator with the Stanford Institute for Materials and Energy Sciences (SIMES). “This opens a whole new world of possibilities that will have an impact beyond this particular study.”
The research team reported its findings in Science today.
New ways to float free and stretch
LCMO, or lanthanum calcium manganese oxide, is what’s known as a quantum material because its electrons behave in unconventional and often surprising ways. Scientists want to be able to control and fine-tune this behavior for a new generation of electronics with applications in power transmission, transportation, computing, sensors and detectors.
Thin films of quantum materials are generally grown on the surface of another material. Four years ago, Hwang’s group reported an easy way to detach those delicate layers so they could be studied in new ways.
One of the researchers who worked on that study, Seung Sae Hong, led this one as well. He used the new method to create and free small pieces of LCMO that were thinner than ever before — less than 20 nanometers thick. They were nearly transparent and surprisingly flexible.
Directly stretching such a small, fragile scrap would be difficult, but Hong got around that problem by putting it on a thin polymer film — kind of like a plastic bag from a grocery store — where it stuck of its own volition.
Then he clamped the polymer film on each of its four sides and used a micromanipulator to pull and stretch it — sometimes in one direction, sometimes in both directions at once. Once the LCMO was stretched, its polymer backing could be glued to another surface and taken to another instrument for examination with X-rays.
Flipping electronic states
“The experiments were quite tedious and difficult,” said Hong, who is now an assistant professor at the University of California, Davis. “We’d look at the film, warm it to soften the glue and relax the stretch, manipulate it in some other way, freeze it in place and look at it again.”
The researchers were able to directly measure the spacing between atoms and confirm that it increased with stretching. They also measured the electrical resistance of the LMCO and discovered that stretching flipped it from a metallic state that readily conducts electricity to an insulating state, which doesn’t. Applying a strong magnetic field changed the magnetic state of the material and also flipped it back into being a metal.
“As a scientific tool this is really exciting,” Hong said. “It opens opportunities for mechanically manipulating broad classes of materials in ways we couldn’t do before. And it gives us ideas for how we might design flexible materials for electronic devices, including sensors and detectors that measure very small changes.”
COVID-19 vaccine candidate shows promise, research shows
University of Pittsburgh School of Medicine scientists today announced a potential vaccine against SARS-CoV-2, the new coronavirus causing the COVID-19 pandemic. When tested in mice, the vaccine, delivered through a fingertip-sized patch, produces antibodies specific to SARS-CoV-2 at quantities thought to be sufficient for neutralizing the virus.
The paper appeared today in EBioMedicine, which is published by The Lancet, and is the first study to be published after critique from fellow scientists at outside institutions that describes a candidate vaccine for COVID-19. The researchers were able to act quickly because they had already laid the groundwork during earlier coronavirus epidemics.
“We had previous experience on SARS-CoV in 2003 and MERS-CoV in 2014. These two viruses, which are closely related to SARS-CoV-2, teach us that a particular protein, called a spike protein, is important for inducing immunity against the virus. We knew exactly where to fight this new virus,” said co-senior author Andrea Gambotto, M.D., associate professor of surgery at the Pitt School of Medicine. “That’s why it’s important to fund vaccine research. You never know where the next pandemic will come from.”
“Our ability to rapidly develop this vaccine was a result of scientists with expertise in diverse areas of research working together with a common goal,” said co-senior author Louis Falo, M.D., Ph.D., professor and chair of dermatology at Pitt’s School of Medicine and UPMC.
Compared to the experimental mRNA vaccine candidate that just entered clinical trials, the vaccine described in this paper — which the authors are calling PittCoVacc, short for Pittsburgh Coronavirus Vaccine — follows a more established approach, using lab-made pieces of viral protein to build immunity. It’s the same way the current flu shots work.
The researchers also used a novel approach to deliver the drug, called a microneedle array, to increase potency. This array is a fingertip-sized patch of 400 tiny needles that delivers the spike protein pieces into the skin, where the immune reaction is strongest. The patch goes on like a Band-Aid and then the needles — which are made entirely of sugar and the protein pieces — simply dissolve into the skin.
“We developed this to build on the original scratch method used to deliver the smallpox vaccine to the skin, but as a high-tech version that is more efficient and reproducible patient to patient,” Falo said. “And it’s actually pretty painless — it feels kind of like Velcro.”
The system also is highly scalable. The protein pieces are manufactured by a “cell factory” — layers upon layers of cultured cells engineered to express the SARS-CoV-2 spike protein — that can be stacked further to multiply yield. Purifying the protein also can be done at industrial scale. Mass-producing the microneedle array involves spinning down the protein-sugar mixture into a mold using a centrifuge. Once manufactured, the vaccine can sit at room temperature until it’s needed, eliminating the need for refrigeration during transport or storage.
“For most vaccines, you don’t need to address scalability to begin with,” Gambotto said. “But when you try to develop a vaccine quickly against a pandemic that’s the first requirement.”
When tested in mice, PittCoVacc generated a surge of antibodies against SARS-CoV-2 within two weeks of the microneedle prick.
Those animals haven’t been tracked long term yet, but the researchers point out that mice who got their MERS-CoV vaccine produced a sufficient level of antibodies to neutralize the virus for at least a year, and so far the antibody levels of the SARS-CoV-2 vaccinated animals seem to be following the same trend.
Importantly, the SARS-CoV-2 microneedle vaccine maintains its potency even after being thoroughly sterilized with gamma radiation — a key step toward making a product that’s suitable for use in humans.
The authors are now in the process of applying for an investigational new drug approval from the U.S. Food and Drug Administration in anticipation of starting a phase I human clinical trial in the next few months.
“Testing in patients would typically require at least a year and probably longer,” Falo said. “This particular situation is different from anything we’ve ever seen, so we don’t know how long the clinical development process will take. Recently announced revisions to the normal processes suggest we may be able to advance this faster.”
Additional authors on the study are Eun Kim, Geza Erdos, Ph.D., Shaohua Huang, Thomas Kenniston, Stephen Balmert, Ph.D., Cara Donahue Carey, Michael Epperly, Ph.D., William Klimstra, Ph.D., and Emrullah Korkmaz, Ph.D., all of Pitt; and Bart Haagmans, of Erasmus Medical Center.
Funding for this study was provided by National Institute of Allergy and Infectious Diseases grant R21-AI114264, National Institute of Arthritis and Musculoskeletal and Skin Diseases grants R01-AR074285, R01-AR071277 and R01-AR068249, and National Cancer Institute grant T32-CA175294.
Health24.com | OPINION: Autistic persons vulnerable during Covid-19 outbreak
As exerted in the implementation matrix of government strategic plan, government and society should work together to combat stereotypes, prejudices and harmful practices relating to persons with disabilities in all spheres of life, writes Hlengiwe Mkhize.
It is World Autism Awareness Day, which this year, we observe during a time where the world faces a Covid-19 outbreak.
The outbreak does not make it easy for such a day to be fully acknowledged, and even giving adequate care to autistic persons and advocating fully, that they too have rights.
During these unprecedented times, they remain vulnerable, even when some should be enjoying their transition to the next phases of their lives.
As the country walks uncharted waters with the nationwide lockdown, and I emphasise that vulnerable groups, including autistic persons should be cared for.
Noting that autism is a developmental disability characterised by difficulties with social interaction and communication, autistic persons should be assisted to ensure that they are protected from contracting Covid-19 as they may be unable to communicate to seek medical help or relay their symptoms.
Due to communication difficulties, autistic persons with autism are also considered a vulnerable group when it comes to Gender-Based Violence, as they may not be able to report incidents of abuse.
In addition, or autistic children with autism, may not understand what abuse is.
Autistic persons could further potentially be more at risk over this time due to the fact that they are not able to access the required support services.
There are going to be unforeseen fallouts of the lockdown. Parents of autistic children are no longer able to access speech, physio, occupational and other important therapy for their child.
It is an established fact that early intervention services for an autistic child could significantly change the developmental trajectory of that child in a positive way.
Just missing one month of therapy will have a major impact on our autistic children. We need to begin exploring ways of how these gaps are going to be addressed once the lockdown has been lifted.
In addition to this, non-speaking autistic persons may be at a heightened risk of all forms of abuse, as they not able to communicate with others.
Unless their caregivers and those who assist them are available, it is unlikely that emergency services, SAPS and the medical fraternity are able to communicate with the autistic person.
Covid-19 has highlighted many gaps in service delivery, and perhaps – once we have returned to a “new normal” – we need to seriously consider engaging with various service providers and stakeholders, to equip them with the required skills to communicate with our non-speaking autistic persons.
To reiterate the UN Secretary General’s words “The rights of persons with autism must be taken into account in the formulation of all responses to the Covid-19 virus.
“On World Autism Awareness Day, let us stand together, support each other and show solidarity with persons with autism,” said António Guterres (UN Secretary General).
According to the United Nations (UN), disease outbreaks affect women and men differently, and pandemics make existing inequalities for women and girls and discrimination of other marginalized groups such as persons with disabilities, worse.
My department will work with counterparts in the security cluster, to ensure that relevant government services remain open during this crucial time to ensure there is adequate support and communication in assisting persons with disabilities.
Guterres says ” … realising the rights of persons with disabilities is a matter of justice as well as an investment in our common future”.
He further added that the UN mission should be “central to achieving the 2030 Agenda for Sustainable Development and leaving no one behind”.
The Department of Women, Youth and Persons with Disabilities calls on all South Africans to take the time to understand Autism Spectrum Disorder, in order to foster acceptance and understanding towards autistic persons. with autism.
As Deputy Minister, I also agree with the UN recommendations when dealing with disabled people, that government should provide accurate and supportive care and messaging with the intention to enhance people’s safety, dignity and rights.
With the help of relevant departments, the enhancement of people’s safety, dignity and rights will be placed as a priority.
More critical, is to ensure the response to Covid-19 does not reproduce or perpetuate harmful discriminatory practices and inequalities post-Covid-19.
Guterres alludes that “persons with autism have the right to self-determination, independence and autonomy, as well as the right to education and employment on an equal basis with others”.
He further explains that the breakdown of vital support systems and networks as a result of Covid-19 exacerbates the obstacles that autistic persons with autism face in exercising these rights.
“We must ensure that a prolonged disruption caused by the emergency does not result in rollbacks of the rights that persons with autism and their representative organizations have worked so hard to advance.”
As exerted in the implementation matrix of government strategic plan, government and society should work together to combat stereotypes, prejudices and harmful practices relating to persons with disabilities in all spheres of life.
While young people remain at home to adhere to lockdown regulations we would like to draw their attention to the need for innovative programmes designed to support autistic youth with autism to navigate the transition to adulthood, and to become full participants in the realisation of the Sustainable Development Goals, both as agents of change and beneficiaries.
– Professor Hlengiwe Mkhize is Deputy Minister in the Presidency for Women, Youth and Persons with Disabilities
Conscious Growth Club Will Open on April 27

In the last week of this month we’ll open Conscious Growth Club for new members. The last time we invited new members to join was in the last week of April 2019, so it’s been a year.
I expect the overall structure of Conscious Growth Club, including the private member forums, member portal, coaching calls, quarterly planning sessions, course access, and monthly 30-day challenges to remain largely unchanged. I’m going to review all the features and benefits, decide what to add or tweak, and record a new invitation video for it, so that’s when I’ll share the exact offer details for the upcoming year.
I intend to keep the price the same: $1997 per year. There are no payment plans and no refunds. It’s meant to be an all-in or nothing type of deal, such that the members who join really want to be a part of it.
Some members have already renewed for the next year early, although I haven’t sent out renewal invitations yet.
The full CGC year runs from May 1 to April 30, although people will get access to the group as soon as they join in the last week of April.
Some people have asked if we’ll open twice this year. While that is a possibility, I don’t have any current plans to do that this year, so I’d say that the chance of a second 2020 opening is very low. Presently I just intend to open CGC once for new members for 2020. The doors will open on April 27, and the doors will close on May 1st. So if you miss it, you’ll have to wait a full year for the opportunity to come around again. As long as you’re on my email list, you’ll be notified about the opening. Or you could mark your calendar to check back on April 27.
Even though people have asked to join mid-year, I haven’t allowed anyone to do so. I like welcoming new members together once per year, so we can be in service mode the rest of the year.
CGC currently has about 150 members. About 60 of them joined last year, and the other 90 joined during the Early Access period. The group initially started in April 2017, so we’ve been going for three years now, and this next year that starts on May 1st will be our fourth year.
Coronavirus and CGC
Given the current virus situation, I thought about how it may impact CGC’s 2020 opening and how we should adapt. So I’ll share my thoughts about that. The short version is that we’re proceeding with the opening as we normally would.
It’s obvious that many people are going to tighten up on their spending right now. For some people, spending $2K on a personal growth program will go on the back burner relative to other expenses like rent and food. I understand and accept that.
I also think there’s a compensating factor, which is that some people will be more likely to invest in CGC right now. They’ll want to take advantage of the resources of the group for helping them through their personal and professional transitions. Having such a group to lean on for a year (or more) will be seriously beneficial for some people who want that kind of support, especially when social media just isn’t doing it for them.
Given the current situation in the world, it would not surprise me if the group shrinks in size after the April opening. But pushing back the opening (and by how much) would be a matter of guesswork, and it might not make things any better. The reality is that there doesn’t seem to be any better time for opening the group relative to the current plan, so I think it’s best to stick with the current opening plans.
Fortunately we’re on very stable financial footing, so I don’t feel any neediness regarding numbers for the next opening. If the group shrinks in size, that’s okay. And if some people want to skip it this year, they’re still welcome to rejoin in a future year.
CGC was designed with resilience in mind. It can function well with 20 members, with 200 members, or with 2000 members. It will just operate differently at different scales. With a small group, it will be more intimate. With a larger group, there will be more energy and activity.
I also like thinking that even when the world is in chaos, CGC can serve as a stabilizing presence for those who want it. While the Olympics may need to be rescheduled, CGC can still open as usual and continue to serve its members through a global crisis.
I’d like this group to endure for decades, so when I think about it from that perspective, it makes sense to proceed with the opening as normal each year, as long as it’s possible to do so. Since this is an entirely online group, it can still function just fine.
I was actually planning to do a new live event in October 2020 in Las Vegas, actually two events back to back. The first part would be a special event just for CGC members so they could connect in person. And the second part would be a new three-day workshop open to all. But I’ve had to take that off the table due to the virus situation. I can’t be certain that the circumstances will allow for a live event at that time. And I’d need to book the dates before the CGC opening, so I could let people know the dates and location. That isn’t possible right now because all of the event spaces in Las Vegas are closed, so we can’t look at meeting rooms even if we wanted to.
I still want to make live events a regular part of CGC as well as doing more workshops for everyone who wants to go, but the current circumstances make it unrealistic to plan anything until we see where the dust settles. And that could be a while, maybe not till 2021 or 2022. In the meantime I’m taking this as a directive to focus more deeply on the online experience of CGC.
Sheltering in Place with CGC
A friend helped me see that CGC is a beautiful group to shelter in place with. It’s a sanctuary for connecting with growth-oriented people in a space free of the craziness that you’ll find elsewhere on social media.
We’ve been actively discussing the coronavirus situation in CGC since February 26th, so our members had a chance to start preparing for this sooner than most people and definitely sooner than the mainstream media caught onto it. Now there are many ongoing discussion threads about adapting to this situation, including trying to predict where things are heading, handling the psychological side, home fitness routines, and more. We even have a check-in thread to keep tabs on members who’ve gotten sick themselves.
Video chats among members seem to be increasing as well. We have a 24/7 video chat channel, so members can talk live whenever they want. While some people are just discovering Zoom today, we’ve been using it since 2017, including for our member coaching calls.
There’s even a discussion about which movies to watch while sheltering in place, and a new subgroup that picks a movie to watch and then discusses it afterwards.
I love seeing how this group has evolved during our first three years, and I’m excited for our future. While I understand and accept that some people will categorize CGC as a non-priority for this year, and I empathize with the reasons they may do so, I think that some people will sensibly prioritize CGC higher precisely because of the circumstances that we’re in now.
Some will want help navigating the uncertainty. Some will want to invest in relationships with people they can trust to be there for them. Some will want to add that stable rock of stability and cool-headedness to their lives.
If you intend to join (or renew) CGC this year, I look forward to sheltering in place with you and supporting you through these current challenges.
And if you decide to pass for this year, I understand and accept that. Please know that you’re welcome to join us in a future year.
And if you’re on the fence, no worries. Just sit tight, and I’ll share plenty of details about CGC as we get closer to the opening week.
Coronavirus: Doctors face agonising life-death decisions
Medics are told they will need to decide who gets the most critical care as coronavirus spreads






